IL6 and breast cancer: IL-6 secretion is crucial for CSC maintenance [44] and sufficient to induce the CD44 + /CD24 low phenotype in breast cancer cell lines and tumors, this supporting the idea that the IL-6-JAK2-STAT3 signal transduction pathway could play an important role in the conversion of non-CSCs into CSCs.